Skip to content

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05267847
Enrollment
188
Registered
2022-03-04
Start date
2022-02-22
Completion date
2022-04-30
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Procedural

Brief summary

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

Interventions

OTHERCryotherapy

local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs

OTHERTraditional local anesthesia

local anesthetic injection with articaine 4% 1:100,000 epinephrine

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy children are classified as I or II according to ASA * Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis * Presence of at least two-thirds of the root length in periapical radiograph

Exclusion criteria

* Unrestorable crowns * Children with systemic, severe behavior or emotional problems * Presence of gingival redness, swellings, fistulous of sinus tract * Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency

Design outcomes

Primary

MeasureTime frameDescription
Pain assessmentup to 24 hoursWong Backer pain scale

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026